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FIRST CLINICAL CASE REPORTFirst bacteraemic human infection with Escherichia albertiiT. J. J. Inglis1,2, A. J. Merritt1,2, N. Bzdyl2, S. Lansley2 and M. N. Urosevic2
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Dentistry and Health Sciences, University of Western Australia, Crawley, Western Australia, AustraliaAbstractThe facultative anaerobic Gram-negative species Escherichia albertii has been isolated from human faeces in gastrointestinal infection and from
a range of wild bird species. Here we report the ﬁrst case of a febrile infection associated with E. albertii bacteraemia in a 76-year-old woman
with gastric dysplasia.
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Other Escherichia species are much less common and are
possibly overlooked unless detailed identiﬁcation procedures
are carried out in all cases of presumptive Escherichia species
bacteraemia. Escherichia albertii was ﬁrst described in 2003 in
association with gastrointestinal infection in Bangladeshi chil-
dren [1]. The species was subsequently identiﬁed in fatal in-
fections of wild birds in several continents [2] but has yet to be
identiﬁed in a bacteraemic human infection.
We describe a case of E. albertii infection in a 76-year-old
woman. The patient had multiple comorbidities: a recent pelvic
fracture from which she was convalescing, a dysplastic polyp of
the gastric fundus with carcinoma-in-situ, hypothyroidism due
to a previous thyroidectomy for papillary carcinoma, epilepsy
and hypertension. She was admitted from residential care with
a febrile illness of undetermined cause, an oral temperature
peaking at 38.7°C, tachycardia at 139 beats per minute and a
respiratory rate of 26 breaths per minute. Blood cultures
collected during febrile episodes over a 24-hour periodNew Microbes and New Infections © 2015 The Authors. Published by El
This is an oresulted in isolation of an oxidase-negative, Gram-negative ba-
cillus from two sets of aerobic and anaerobic bottles inoculated
on separate occasions. MALDI-TOF (matrix-assisted laser
desorption/ionization time-of-ﬂight mass spectrometry) analysis
with direct extraction from blood cultures resulted in pre-
sumptive identiﬁcation of Escherichia coli (score > 2.0; Biotyper,
Bruker Daltonik, Germany). Targeted identiﬁcation of blood
culture isolates identiﬁed E. coli (score > 2.0, no alternative
species listed). The patient was treated initially with piperacillin/
tazobactam intravenously for 72 hours and then after defer-
vescence with oral ciproﬂoxacin 500 mg twice daily. There
were no clinical features of gastrointestinal infection. A
midstream urine specimen contained >100 × 106 leucocytes
per litre and a few bacteria on centrifuged deposit, but no
signiﬁcant bacterial growth. She defervesced rapidly and made
an uneventful clinical recovery.
The possibility of an alternative aetiology was only consid-
ered when a molecular method of identifying common causes
of bacteraemia (ﬁlm array; BioFire, bioMérieux, France) pro-
duced a discrepant result: positive for Enterobacteriaceae but
negative for E. coli. All isolates were oxidase-negative, Gram-
negative bacilli on 5% horse blood agar and initially non-lactose-
fermenting colonies on MacConkey agar. We identiﬁed them by
substrate utilization (API 20E, bioMérieux), resulting in a low
discrimination E. coli identiﬁcation (results of tests against were
urease positive, rhamnose and melibiose negative). Glucose,New Microbe and New Infect 2015; 8: 171–173
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FIG. 1. Neighbour-joining tree depicting 16S rRNA gene sequence of STRAIN PERTH and related taxa. GenBank accession numbers are shown in
brackets.
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tests in the panels were consistently positive. An isolate extract
was prepared for 16S-based identiﬁcation, which was consistent
with E. albertii (Fig. 1). Though the patient had no history of
gastrointestinal infection symptoms such as diarrhoea, we
sought evidence of Shiga toxin [3] by PCR assay and tissue
culture cytotoxin assay. Both were negative. The patient had no
recent contact with birds, caged or otherwise, young children
or other family members with active diarrhoea; no recent
history of travel outside the Perth metropolitan area; and no
investigations in the preceding months for diarrhoea or other
clinical features of gastrointestinal infection. No bird die-off had
been reported in the state during the previous 6 months.
The aetiology of this infection would have been missed had it
not been for the discrepancy we recorded between the
MALDI-TOF results and the ﬁlm array identiﬁcation of the
blood culture isolates because the urinary leucocytosis was
interpreted as presumptive evidence of urosepsis, and the initial
identiﬁcation of E. coli isolated from repeated blood cultures
was taken as further evidence of urosepsis. The phenotypic
features of E. albertii are sufﬁciently variable to render classic
phenotypic identiﬁcation methods unreliable [4], and even theNew Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
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E. coli result for all blood culture isolates. Although the erro-
neous identiﬁcation of E. coli did not result in inappropriate
clinical management, the opportunity for early public health
intervention against a cluster of gastrointestinal infection cases
might have been missed if the strain had been Shiga toxin
positive [5,6]. It is of particular note the woman had no
epidemiologic connection with sick birds or children, as
documented in early reports of E. albertii infection [1,2].
E. albertii has recently been recognized as an early speciation
event close to the separation of E. coli and Shigella species and
has complex genomic diversity [7]. The addition of clinically
signiﬁcant E. albertii strains to culture collections used for
identiﬁcation databases will assist in timely recognition of this
emerging pathogen and will help clarify whether this species is
responsible for a wider spectrum of human disease than orig-
inally thought.Conﬂict of interestNone declared.European Society of Clinical Microbiology and Infectious Diseases, NMNI, 8, 171–173
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